Clinical Research Directory
Browse clinical research sites, groups, and studies.
Scrambler Therapy in Chronic Pancreatitis
Sponsor: Johns Hopkins University
Summary
The investigators will enroll adults with chronic pancreatitis who have persistent abdominal pain not relieved by standard treatments. This study will test the feasibility and effectiveness of Scrambler Therapy, a non-invasive FDA-cleared device that delivers "non-pain" electrical signals through the skin to retrain the brain's pain perception. Participants will undergo 5-10 treatment sessions and be followed for 3 months with standardized pain scores and quality-of-life assessments. The goal is to generate pilot data to support larger studies of Scrambler Therapy as a novel option for pancreatic pain.
Official title: A Pilot Study of Scrambler Therapy for Painful Chronic Pancreatitis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-11-01
Completion Date
2026-12-01
Last Updated
2025-09-16
Healthy Volunteers
No
Interventions
Scrambler Therapy
Adults with chronic pancreatitis and refractory abdominal pain will receive Scrambler Therapy, a non-invasive neuromodulation device. Electrodes are placed near the painful area to deliver "non-pain" signals aimed at reducing pain perception. Participants will complete 5-10 daily treatment sessions, each lasting 30-40 minutes, with pain ratings collected before and after sessions and follow-up assessments over 3 months.
Locations (1)
Johns Hopkins Green Spring Station
Baltimore, Maryland, United States